Ionis Pharmaceuticals, Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
Ionis Pharmaceuticals, Inc. (IONS) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $315.46 million as of 2023-09-30, per its 10-Q filed 2023-11-02.
Discontinued › Balance Sheet › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2023-11-02
- 2023-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $315.46M.
- 2023-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $428.30M.
- 2023-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $486.57M.
- 2022-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $572.89M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2023-09-30 | $315.46M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $428.30M 10-Q · filed 2023-11-02 | |
| 2023-03-31 | $486.57M 10-Q · filed 2023-08-09 | |
| 2022-12-31 | $572.89M 10-Q · filed 2023-11-02 | |
| 2022-09-30 | $594.36M 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $624.73M 10-Q · filed 2023-11-02 | |
| 2022-03-31 | $709.57M 10-Q · filed 2023-08-09 | |
| 2021-12-31 | $771.74M 10-Q · filed 2023-11-02 | |
| 2021-09-30 | $530.54M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $582.67M 10-Q · filed 2022-11-09 | |
| 2021-03-31 | $680.56M 10-Q · filed 2022-08-09 | |
| 2020-12-31 | $743.28M 10-K · filed 2023-02-22 | $843.35M 10-K · filed 2021-02-24 |
| 2020-09-30 | $1.52B 10-Q · filed 2021-11-03 | $1.61B 10-Q · filed 2020-11-04 |
| 2020-06-30 | $1.50B 10-Q · filed 2021-11-03 | $1.59B 10-Q · filed 2020-08-05 |
| 2020-03-31 | $1.47B 10-Q · filed 2021-08-04 | $1.57B 10-Q · filed 2020-05-06 |
| 2019-12-31 | $1.58B 10-K · filed 2023-02-22 | $1.68B 10-K · filed 2020-03-02 |
| 2019-09-30 | $1.50B 10-Q · filed 2020-11-04 | |
| 2019-06-30 | $1.46B 10-Q · filed 2020-11-04 | |
| 2019-03-31 | $1.39B 10-Q · filed 2020-08-05 | |
| 2018-12-31 | $1.10B 10-K · filed 2022-02-25 | $1.19B 10-K · filed 2019-03-01 |
| 2018-09-30 | $840.14M 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $817.44M 10-Q · filed 2019-11-06 | |
| 2018-03-31 | $387.10M 10-Q · filed 2019-08-08 | |
| 2017-12-31 | $365.28M 10-K · filed 2021-02-24 | $418.72M 10-K · filed 2018-02-28 |
| 2017-09-30 | $397.67M 10-Q · filed 2017-11-07 | |
| 2016-12-31 | $39.61M 10-K · filed 2020-03-02 | $99.56M 10-K · filed 2017-03-01 |
| 2015-12-31 | $200.79M 10-K · filed 2019-03-01 | |
| 2014-12-31 | $257.78M 10-K · filed 2018-02-28 | |
| 2013-12-31 | $378.39M 10-K · filed 2017-03-01 | |
| 2012-12-31 | $182.77M 10-K · filed 2016-02-26 | |
| 2011-12-31 | $171.43M 10-K · filed 2015-03-02 | |
| 2011-06-30 | $212.22M 10-Q · filed 2011-08-08 | |
| 2011-03-31 | $227.70M 10-Q · filed 2011-05-06 | |
| 2010-12-31 | $244.54M 10-K · filed 2014-03-03 | |
| 2010-09-30 | $253.71M 10-Q · filed 2010-11-05 | |
| 2010-06-30 | $262.23M 10-Q · filed 2010-08-09 | |
| 2009-12-31 | $302.06M 10-K · filed 2013-02-28 | |
| 2008-12-31 | $147.38M 10-K · filed 2012-02-29 | |
| 2007-12-31 | $59.59M 10-K · filed 2011-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |